Alzheimer's disease early screening and staged detection with plasma proteome using machine learning and convolutional neural network
European Journal of Neuroscience · 2024
DOI: 10.1111/ejn.16392 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Neuroscience, 2024. Verfasst von Hengyu Qin und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Information and Electronics, Beijing Institute of Technology, Beijing, China. Hauptthemen laut MEDLINE: Alzheimer Disease, Machine Learning, Neural Networks, Computer, Early Diagnosis. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 44 Literaturangaben.
Abstract (Originalsprache)
Alzheimer's disease (AD) stands as the prevalent progressive neurodegenerative disease, precipitating cognitive impairment and even memory loss. Amyloid biomarkers have been extensively used in the diagnosis of AD. However, amyloid proteins offer limited information about the disease process and accurate diagnosis depends on the presence of a substantial accumulation of amyloid deposition which significantly impedes the early screening of AD. In this study, we have combined plasma proteomics with an ensemble learning model (CatBoost) to develop a cost‐effective and non‐invasive diagnostic method for AD. A longitudinal panel has been identified that can serve as reliable biomarkers across the entire progression of AD. Simultaneously, we have developed a neural network algorithm that utilizes plasma proteins to detect stages of Alzheimer's disease. Based on the developed longitudinal panel, the CatBoost model achieved an area under the operating curve of at least 0.90 in distinguishing mild cognitive impairment from cognitively normal. The neural network model was utilized for the detection of three stages of AD, and the results demonstrated that the neural network model exhibited an accuracy as high as 0.83, surpassing that of the traditional machine learning model.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Information and Electronics, Beijing Institute of Technology, Beijing, China.
- The Department of Information Engineering, The Chinese University of Hong Kong, Hong Kong, China.
- Changping Laboratory, Beijing, China.
- Department of Critical Care Medicine, Renmin Hospital of Wuhan University, Wuhan, China.
ORCID-Profile: Hengyu Qin, Xiumin Shi, Yibo Zhu, Lu Wang
Zitieren
APA
Qin, H., Shi, X., Zhu, Y., Ma, J., Deng, X., & Wang, L. (2024). Alzheimer's disease early screening and staged detection with plasma proteome using machine learning and convolutional neural network. European Journal of Neuroscience. https://doi.org/10.1111/ejn.16392
Vancouver
Qin H, Shi X, Zhu Y, Ma J, Deng X, Wang L. Alzheimer's disease early screening and staged detection with plasma proteome using machine learning and convolutional neural network. European Journal of Neuroscience. 2024. doi:10.1111/ejn.16392
BibTeX
@article{Qin2024,
author = {Qin, Hengyu and Shi, Xiumin and Zhu, Yibo and Ma, Jiacheng and Deng, Xiaohong and Wang, Lu},
title = {Alzheimer's disease early screening and staged detection with plasma proteome using machine learning and convolutional neural network},
journal = {European Journal of Neuroscience},
year = {2024},
doi = {10.1111/ejn.16392}
}
EUVIMED